Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Si-Bone (SIBN) Research & Development (2017 - 2026)

Si-Bone has reported Research & Development over the past 10 years, most recently at $4.2 million for Q1 2026.

  • For Q1 2026, Research & Development fell 7.54% year-over-year to $4.2 million; the TTM value through Mar 2026 reached $17.1 million, up 2.13%, while the annual FY2025 figure was $17.4 million, 5.36% up from the prior year.
  • Research & Development for Q1 2026 was $4.2 million at Si-Bone, down from $4.4 million in the prior quarter.
  • Over five years, Research & Development peaked at $4.5 million in Q1 2025 and troughed at $3.1 million in Q3 2022.
  • A 5-year average of $3.9 million and a median of $4.0 million in 2024 define the central range for Research & Development.
  • Biggest five-year swings in Research & Development: dropped 8.07% in 2023 and later skyrocketed 32.03% in 2024.
  • Year by year, Research & Development stood at $3.5 million in 2022, then increased by 19.6% to $4.2 million in 2023, then dropped by 7.02% to $3.9 million in 2024, then increased by 12.74% to $4.4 million in 2025, then decreased by 3.92% to $4.2 million in 2026.
  • Business Quant data shows Research & Development for SIBN at $4.2 million in Q1 2026, $4.4 million in Q4 2025, and $4.2 million in Q3 2025.